Contrast
Contact
Share
MyChart
Radiology, Vascular/Interventional, Diagnostic Radiology
Aneurysms, Angioplasty, Arteriovenous Malformation (AVM), Biopsies, Cancer, Carotid Artery Disease, Chemoembolization, Deep Vein Thrombosis (DVT), Embolization, Embolotherapy, Endovascular Surgery, Fibroid Embolization, Kidney Cancer, Kidney Stones, Laser Surgery (Varicose Veins), Liver Cancer, Minimally Invasive Surgery, Paracentesis, Pelvic Congestion Syndrome, Periperal Arterial Evaluation, Radiofrequency Ablation, Renal and Visceral Artery Disease, Renal Artery Stenosis, Revascularization, Stent, UFE - Uterine Fibroid Embolization, Uterine Fibroid Embolization, Uterine Fibroids, Varicocele Embolization, Varicose Veins, Vascular Malformations, Women's Health
Male
English
33
Read BiographyColumbia University;Columbia University College of Physician & Surgeons (1979;1983)
Columbia Presbyterian Medical Center (1988)
University of Pennsylvania Hospital (1989)
20 York Street
Yale New Haven Hospital
New Haven, CT 06510
Main (203) 785-4747
Fax (203) 737-1077
800 Howard Ave
New Haven, CT 06519
Main (203) 785-4747
Fax (203) 737-1077
267 Grant St
Bridgeport Hospital
Bridgeport, CT 06610
Main (203) 384-3717
Fax (203) 384-4132
Insurance coverage regularly changes, please contact the doctor’s office directly to verify that your specific insurance plan is accepted.
Phone
(203) 785-4747Jeffrey Pollak, MD, is a vascular and interventional radiologist who specializes in the minimally invasive treatment of blood vessel abnormalities (including occlusions and abnormally developed vessels) and of tumors.
While active in all aspects of vascular and interventional radiology, Dr. Pollak’s current major interests are embolotherapy (embolization) for acquired and congenital vascular abnormalities and malformations (other than in the brain), fibroids, and malignancies, as well as other minimally invasive treatments for tumors, such as local ablation, particularly in the liver and kidney.
“For smaller and more limited tumors, the preferred method is local ablation. The second method is the delivery of material through the liver artery supplying the tumor to injure and destroy it,” Dr. Pollak explains. “The injected material commonly consists of concentrated chemotherapy mixed with other material, usually special plastic beads, but also may consist of special radiation-emitting beads to create internal radiation therapy.”
Dr. Pollak, who says he mixes honesty with humor to reassure patients and make them feel comfortable, is an expert in vascular procedures in the liver, such as intrahepatic portosystemic shunts and venous procedures, including inferior vena cava filters and opening blocked veins.
Dr. Pollak is the director of the multidisciplinary Yale Hereditary Hemorrhagic Telangiectasia Program, which was started as the first of its kind in the world in the early 1990s. As such, he has extensive experience in the evaluation and management of patients with this genetic disorder, with particular expertise in embolization of pulmonary arteriovenous malformations, which frequently occur in this population.
Additionally, he is the co-director of the Yale Pulmonary Embolism Response Team, a group of physicians interested in the advancement of the management of patients with this condition, especially those with more severe manifestations.
Is this your profile? Request an Edit »